CapForce Inc.
CFOR- Exchange
- OTC
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001293818
No open-market purchases or sales by CapForce Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in CapForce Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- −4 vs. Q4 2023
- Shares held
- 464.5K
- +170.7K (+58.1%) vs. Q4 2023
- Total value
- $322.1K
- +$198.4K (+160.4%) vs. Q4 2023
- New holders
- 3
- 2 more added
- Sold out
- 7
- 3 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CFOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $6 |
| Q2 2024 | 7 | $12.3K |
| Q1 2024 | 13 | $322.1K |
| Q4 2023 | 17 | $123.7K |
| Q3 2023 | 14 | $121.5K |
| Q2 2023 | 12 | $586.6K |
| Q1 2023 | 16 | $329.2K |
| Q4 2022 | 26 | $521.8K |
| Q3 2022 | 23 | $2.52M |
| Q2 2022 | 25 | $1.88M |
| Q1 2022 | 28 | $3.08M |
| Q4 2021 | 31 | $5.11M |
| Q3 2021 | 23 | $8.44M |
| Q2 2021 | 28 | $5.31M |
| Q1 2021 | 31 | $5.06M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding CapForce Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Chase Investment Counsel Corp | 331,890 | $230.0K | 0.09% | +331,890 | New |
| Vanguard Group Inc | 53,275 | $37.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 36,301 | $25.2K | 0.00% | −454−1.2% | Reduced |
| Boston Private Wealth LLC | 18,219 | $12.7K | 0.00% | +18,219 | New |
| BlackRock Inc. | 15,941 | $11.1K | 0.00% | −99−0.6% | Reduced |
| Tower Research Capital LLC (TRC) | 7,436 | $5.17K | 0.00% | +194+2.7% | Added |
| Qube Research & Technologies Ltd | 1,200 | $834 | 0.00% | +1,000+500.0% | Added |
| Wells Fargo & Company | 78 | $54 | 0.00% | −173−68.9% | Reduced |
| GWM Advisors LLC | 50 | $35 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 13 | $9 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 50 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas | 1 | $0 | 0.00% | +1 | New |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −66,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −40,384−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −36,377−100.0% | Sold out |
| Connective Capital Management, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,102−100.0% | Sold out |
| Focused Wealth Management, Inc | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −1−100.0% | Sold out |